Group 1 - The core point of the announcement is the resolution of the third extraordinary general meeting of shareholders held by Runben Biotechnology Co., Ltd. on November 5, 2025, with no resolutions being rejected [1][2]. - The meeting was convened by the board of directors and chaired by Mr. Zhao Guiqin, with a combination of on-site and online voting methods, complying with the Company Law and the company's articles of association [2][3]. - All six current directors attended the meeting, along with the board secretary [3]. Group 2 - One of the key resolutions passed was the reappointment of the accounting firm, which was approved by the shareholders [4]. - The meeting was witnessed by Guangdong Guangxin Junda Law Firm, with lawyers Zhang Wei and Ma Xiaoxi confirming the legality and validity of the meeting's procedures and resolutions [5].
润本生物技术股份有限公司2025年第三次临时股东会决议公告